A popular drug used for diabetes and weight loss may also help protect the brain. That’s the key message from a new study ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...

Premature permanent discontinuation of oral semaglutide or placebo occurred in 1309 participants (27.1%) in the oral semaglutide group and in 1373 participants (28.5%) in the placebo group (Fig. S3B).

Semaglutide works by slowing down gut motility, or the speed at which food moves through the digestive tract, which may also have an effect on gut bacteria, according to Salhab.

At 3 years, rates of the composite outcomes increased to 5.9% and 6.9% for those treated with semaglutide and empagliflozin, respectively, corresponding to an HR of 0.89 (95% CI, 0.78-1.02).

A recent study linked GLP-1 (glucagon-like peptide-1) agonists — the class of drugs that includes semaglutides — to an increased risk of hair loss. Here's what you should know.

The researchers analyzed data from 16 million patients from a health claims database, narrowing it down to 1,926 semaglutide users and 1,348 users of bupropion-naltrexone, another type of weight ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are sometimes taken off-label for weight loss.